A C-terminal analog of the hexapeptide orphanin FQ/nociceptin-(1-6), [Ala(6
)]-orphanin FQ/nociceptin-(1-6), and a pentapeptide orphanin FQ/nociceptin-
(1-5) were tested in vivo for their analgesic/hyperalgesic activity in the
hot-plate test with rats. Replacement of the C-terminal glycine by L-alanin
e (Phe-Gly-Gly-Phe-Thr-Ala) in orphanin FQ/nociceptin-(1-6) abolished the h
yperalgesic potency of native orphanin FQ/nociceptin-(1-6) (Phe-Gly-Gly-Phe
-Thr-Gly), but analgesic activity was retained and was diminished by naloxo
ne. Removal of the C-terminal amino acid (glycine or alanine) from orphanin
FQ/nociceptin-(1-6) caused a significant loss of analgesic activity. It is
anticipated that glycine plays a crucial role in the biphasic activity of
orphanin FQ/nociceptin-(1-6). This may suggest the existence of a mechanism
for terminating the biological action of orphanin FQ/nociceptin. (C) 2001
Elsevier Science B.V. All rights reserved.